Global Vitamin D Therapy Market Size, Key Driving Factors, Booming Company| Abbott Laboratories, Novartis International AG, Torrent Pharmaceuticals Ltd., Merck & Co.

 

Global Vitamin D Therapy Market

Vitamin D is defined as the fat-soluble vitamin which is responsible for maintaining healthy bones & teeth. Although our body cannot produce Vitamin D, it is mainly obtained by the cutaneous production during sun exposure. The deficiency of vitamin D causes to bone pain & weakened muscles. Vitamin D therapy is provided to treat various conditions including rickets, muscle weakness, osteoporosis, skin diseases, and others.

The increase in target patient population is the key driving factor which expected to boost the global vitamin D therapy market growth over the forecast period. Furthermore, the growing awareness about vitamin D deficiency, the rise in patient compliance to oral medications, growing prevalence of hypovitaminosis D, sedentary lifestyles, aging population, and lack of exposure to sun are some prominent factors which expected to drive the global vitamin D therapy market growth.

Get Request Free Sample @ https://qualiketresearch.com/request-sample/Vitamin-D-Therapy-Market/request-sample

Moreover, strategic acquisitions and mergers among companies contribute to the growth of the vitamin D therapy market. For Instance, in 2018, GSK completed the buyout of Novartis’ 36.5% stake in Consumer Healthcare Joint Venture as well as GSK had entered into collaboration with Pfizer to form a consumer health care joint venture which would provide a range of products in vitamin & mineral supplements, therapeutic oral health, skin health, respiratory, pain relief, and digestive health, and others. 

 Also, the rise in use of vitamin D in the treatment of diseases is expected to provide a significant opportunity to the market of vitamin D therapy. For Instance, research article published in “Clinical Breast Cancer”, a magazine published by Elsevier found that vitamin D supplement intake with chemotherapy can advance disease-free survival in women with HER2+ breast cancer. The study reveals that patients who consumed Vitamin D supplements during treatment have better survival as compared to the patients who did not take vitamin D supplements. This research is expected to propel the Vitamin D therapy market growth in near future.

The increase in cases of a medical condition associated with the excessive consumption of Vitamin D is expected to restrict the market growth of Vitamin D therapy market. High level of Vitamin D in the body can cause Vitamin D toxicity commonly called as Hypervitaminosis D. Though it is rare, but the serious condition can result in a buildup of excess calcium in the blood which is called as hypercalcemia. Therefore, excessive consumption of Vitamin D can occur serious medical conditions, this factor is anticipated to hamper the market growth of Vitamin D therapy market. 

Market Segmentation 

The Global Vitamin D Therapy Market is segmented into route of administration such as Oral, and Parenteral. The oral route is anticipated to register the largest share and highest CAGR during the forecast period. Due to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route.

Further, market is segmented into application such as Rickets, Muscle Weakness, Osteoporosis, Skin Diseases, and Others. The osteoporosis segment is anticipated to register the highest growth over the forecast period. This growth can be attributed to the growing incidence of falls & fractures in senior adults due to the elevated levels of parathyroid hormones and the poor absorption of calcium from their diets. 

Regional Analysis 

The Global Vitamin D Therapy Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

The Asia Pacific is expected to expand at the highest CAGR during the forecast period, owing to the awareness about vitamin D deficiency as well as supportive government policies & programs for the implementation of vitamin D deficiency treatment plans, sedentary lifestyles, growing incidence of vitamin D deficiency, decreasing sun exposure, atypical diets, and rising malnutrition levels.

Also, the North America is anticipated to dominates the vitamin D therapy market during this forecast timeline. Due to the presence of leading players based in the United States, focus on research activities to develop more patient compliant products with enhanced efficiency along with the government support & the increase in healthcare expenditure contributing to its outstanding market revenue share in the overall market growth. 

Key Players Analysis 

Various key players are listed in this report such as Abbott Laboratories, Novartis International AG, Torrent Pharmaceuticals Ltd., Merck & Co., Inc., Sanofi, Pfizer, Inc., Cadila Healthcare Ltd., Sun Pharmaceutical Industries Ltd, Biotics Research Corporation, Alkem Laboratories Ltd, etc. Abbott Laboratories has a global distribution network & a good brand reputation among end users. The company’s strong presence as well as wide distribution channels across the world have helped it to maintain its leading position in the market. The company focusing on the mergers & acquisitions, with strategic alliances such as technology, licensing, to obtain an edge over competitors.

Market Taxonomy

By Route of Administration

·         Oral

·         Parenteral

By Application

·         Rickets

·         Muscle Weakness

·         Osteoporosis

·         Skin Diseases

·         Others

By Region

·         North America

·         Latin America

·         Europe

·         Asia Pacific

·         Middle East & Africa

Browse full Report @ https://qualiketresearch.com/reports-details/Vitamin-D-Therapy-Market

About Us

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which help our clients outperform their competition.